📖

NR2B (GluN2B) NMDA Receptor Subunit

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-nr2b

Related Entities

Metadata

slug	proteins-nr2b
entity_type	protein
kg_node_id	NR2B

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (29)

see_also📖Epigenetic Clocks in Neurodegeneration — Causal Drivers or P60%

see_also📖Packard Center for ALS Research60%

see_also📖NeuRon Therapeutics60%

see_also📖Neurodegeneration60%

see_also📖Genes60%

see_also📖DLG4 Gene - PSD-9560%

see_also📖FOS Gene60%

see_also📖GRIN2B — NMDA Receptor Subunit 2B60%

see_also📖NPAS4 Gene60%

see_also📖DLG4 Gene60%

mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy50%

mentions🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto50%

mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering50%

mentions🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬What are the mechanisms underlying perivascular spaces and g50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬What are the mechanisms underlying perivascular spaces and g50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br50%

mentions🔬Analyze circuit-level changes in neurodegeneration using All40%

mentions🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br40%

related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m40%

related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto40%

related🧪Magnetosonic-Triggered Transferrin Receptor Clustering40%

related🧪Gamma entrainment therapy to restore hippocampal-cortical sy40%